Posted in | News | Renewable Energy | Wind Power

Notice of Allowance Received for CGE Energy’s Additional WIND-e20 Wind Turbine Patent

CGE Energy is pleased to announce that it has received a Notice of Allowance for its patent application titled, “Fluid driven vertical axis turbine.”

This patent includes multiple independent claims that cover many aspects of CGE Energy’s WIND-e20® vertical axis wind turbine, including its easy delivery, collapsible blades and crane-less installation.

“It has been a long patent process, especially when you are inventing technologies that will revolutionize the renewable energy sector,” said CGE Energy President and CEO Bryan Zaplitny.

The patent covers the unique hydraulic locking joints within the turbine’s segmented blades, which allow them to collapse flat against the rotor. As another claim in the patent, a hydraulic lifting and transport frame enables the turbine to be delivered on a flatbed truck and can lie flat for maintenance without the need of a crane. Conversely, traditional horizontal wind turbines are assembled after delivery and require costly cranes for installation and repair.

Collapsible blades not only ease delivery and maintenance, but also guarantee better security. WIND-e20® can automatically collapse its blades at the first sign of hurricane winds. This means it can survive in some of the windiest locations on the planet, including the Caribbean, where WIND-e20® technology will be used in the near future. Burtek Enterprises, a five-star military contractor, is CGE Energy’s strategic partner for the manufacturing of WIND-e20®.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.